Hung Huynh Selected Research

Hung Huynh Research Topics

Disease

36	Neoplasms (Cancer) 01/2024 - 03/2002
30	Hepatocellular Carcinoma (Hepatoma) 01/2024 - 03/2002
8	Neoplasm Metastasis (Metastasis) 01/2024 - 09/2003
4	Retinoblastoma (Glioblastoma, Retinal) 08/2012 - 03/2004
4	Liver Neoplasms (Liver Cancer) 03/2010 - 03/2002
3	Carcinogenesis 10/2021 - 10/2004
3	Hypoxia (Hypoxemia) 11/2020 - 11/2007
3	Ascites 07/2008 - 11/2007
3	Body Weight (Weight, Body) 12/2004 - 06/2002
2	Renal Cell Carcinoma (Grawitz Tumor) 01/2017 - 08/2012
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2017 - 07/2015
2	Stomach Neoplasms (Stomach Cancer) 10/2015 - 09/2009
2	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 04/2015 - 01/2009
2	Carcinoma (Carcinomatosis) 11/2007 - 12/2004
2	Prostatic Neoplasms (Prostate Cancer) 05/2004 - 09/2003
2	Keloid 04/2003 - 07/2002
1	Weight Loss (Weight Reduction) 01/2023
1	COVID-19 02/2022
1	Tics (Tic) 08/2017
1	Adenocarcinoma of Lung 01/2017
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2015
1	Tuberous Sclerosis (Bourneville's Disease) 05/2015

Drug/Important Bio-Agent (IBA)

9	Sorafenib (BAY 43-9006)FDA Link 01/2024 - 01/2009
8	Phosphotransferases (Kinase)IBA 12/2020 - 09/2003
8	Proteins (Proteins, Gene)FDA Link 04/2020 - 01/2004
6	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 10/2021 - 10/2008
6	AZD 6244IBA 08/2012 - 01/2007
6	Sirolimus (Rapamycin)FDA Link 03/2010 - 11/2007
5	Vinorelbine (Navelbine)FDA LinkGeneric 01/2024 - 01/2019
5	infigratinibIBA 10/2021 - 01/2019
5	Bevacizumab (Avastin)FDA Link 12/2020 - 11/2007
5	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2019 - 08/2003
4	TOR Serine-Threonine KinasesIBA 03/2010 - 11/2007
4	QuercetinIBA 06/2004 - 09/2003
3	Everolimus FDA Link 12/2023 - 07/2009
3	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 10/2021 - 11/2020
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021 - 11/2007
3	Cyclin B1IBA 03/2012 - 09/2007
3	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 09/2009 - 11/2007
2	SurvivinIBA 12/2023 - 01/2017
2	70-kDa Ribosomal Protein S6 Kinases (Ribosomal Protein S6 Kinases, 70 kDa)IBA 12/2023 - 08/2012
2	roblitinibIBA 10/2021 - 11/2020
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 11/2020
2	Epithelial Cell Adhesion MoleculeIBA 08/2017 - 08/2013
2	Cisplatin (Platino)FDA LinkGeneric 01/2017 - 07/2015
2	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 08/2012 - 03/2012
2	Mitogen-Activated Protein KinasesIBA 03/2010 - 08/2003
2	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 09/2009 - 01/2007
2	Doxorubicin (Adriamycin)FDA LinkGeneric 06/2008 - 09/2007
2	Cyclin D1IBA 11/2007 - 09/2007
2	Hormones (Hormone)IBA 10/2007 - 09/2003
2	2- ((((2- chloroethyl)nitrosoamino)carbonyl)amino)propanamide (SarCNU)IBA 07/2006 - 12/2004
2	Antineoplastic Agents (Antineoplastics)IBA 12/2004 - 05/2004
2	Messenger RNA (mRNA)IBA 01/2004 - 07/2002
2	MitogensIBA 04/2003 - 03/2002
2	Insulin-Like Growth Factor Binding Protein 3IBA 04/2003 - 03/2002
1	Focal Adhesion Protein-Tyrosine KinasesIBA 01/2024
1	CholesterolIBA 01/2023
1	VaccinesIBA 02/2022
1	Granzymes (Granzyme)IBA 10/2021
1	ribociclibIBA 01/2021
1	Angiogenesis InhibitorsIBA 12/2020
1	tyrosine receptor (receptor, tyrosine)IBA 01/2020
1	SHP099IBA 01/2020
1	N- (3,4- difluoro- 2- (2- fluoro- 4- iodophenylamino)- 6- methoxyphenyl)- 1- (2,3- dihydroxypropyl)cyclopropane- 1- sulfonamideIBA 01/2019
1	Glycoproteins (Glycoprotein)IBA 08/2017
1	sepantroniumIBA 01/2017
1	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2017
1	belinostatIBA 01/2017
1	UbiquitinIBA 01/2017
1	auristatinIBA 11/2016
1	Immunoconjugates (Immunoconjugate)IBA 11/2016
1	aprutumab ixadotinIBA 11/2016
1	RNA (Ribonucleic Acid)IBA 10/2015
1	regorafenibIBA 10/2015
1	AntibodiesIBA 10/2015
1	Trastuzumab (Herceptin)FDA Link 10/2015
1	RamucirumabIBA 10/2015
1	saracatinibIBA 10/2015
1	mirdametinibIBA 10/2015
1	trans-sodium crocetinate (crocetin)IBA 05/2015
1	Mechanistic Target of Rapamycin Complex 1IBA 05/2015
1	Imatinib Mesylate (Gleevec)FDA Link 04/2015
1	GadoliniumIBA 04/2014
1	ProdrugsIBA 08/2013
1	Cytosine DeaminaseIBA 08/2013
1	LuciferasesIBA 08/2013
1	Apolipoproteins E (ApoE)IBA 08/2013
1	ApolipoproteinsIBA 08/2013
1	3-deazaneplanocinIBA 08/2013
1	Flucytosine (Ancobon)FDA Link 08/2013
1	Complement System Proteins (Complement)IBA 08/2012
1	GSK 1363089IBA 03/2012
1	4- amino- 5- fluoro- 3- (5- (4- methylpiperazin- 1- yl)- 1H- benzimidazol- 2- yl)quinolin- 2(1H)- oneIBA 03/2012
1	Histones (Histone)IBA 03/2012
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 07/2011

Therapy/Procedure

8	Therapeutics 01/2024 - 09/2009
5	Drug Therapy (Chemotherapy) 12/2023 - 07/2008
1	Aftercare (After-Treatment) 01/2021
1	Radiotherapy 04/2020